1 - The demonstration of the reciprocal, opposing actions of cyclic AMP and cyclic GMP on neuronal excitability
Stone TW, Taylor DA & Bloom FE. (1975)
Cyclic AMP and cyclic GMP may mediate opposite neuronal responses in the rat cerebral cortex.
Science 187, 845-847.
2 - pharmacological evidence, in vivo, for glutamate as an excitatory neurotransmitter in the brain
Stone TW. (1976)
Blockade by amino acid antagonists of neuronal excitation mediated by the pyramidal tract.
- Physiol.(Lond.) 257, 187-198. ].
3 - The discovery of the role of adenosine in mediating effects of morphine in the brain
Stone TW &. Perkins MN. (1979)
Is adenosine the mediator of opiate actions on neuronal firing rate?
Nature 281, 227-228.
4 - modulation of glutamate receptor function by the kynurenine pathway (see below). Quinolinic acid was found to be an agonist at NMDA receptors while kynurenic acid was later shown to be an antagonist
Stone, T.W. & Perkins, M N. (1981)
Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS.
Europ. J.Pharmacol. 72, 411-412
Perkins MN & Stone TW. (1982)
An iontophoretic investigation of the action of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid.
Brain Research 247, 184-187.
5 – the first evidence for biological activity of adenine dinucleotides
Stone TW (1981)
Actions of adenine dinucleotides on the vas deferens, guinea-pig taenia caeci and bladder.
Europ. J. Pharmacol. 75, 93-102.
6 - The functional demonstration of the neural control of brown adipose tissue from the hypothalamus
Perkins MN, Rothwell N, Stock MJ & Stone TW. (1981)
Activation of brown adipose tissue thermogenesis by the ventromedial hypothalamus.
Nature 289, 401-402.
7 - The discovery of the biological activity of amine conjugates with bicarbonate, a finding with major implications for the physiological activity of amines under conditions of varying acidity and carbon dioxide tension.
Lloyd HGE, Perkins MN & Stone TW (1982)
Ethylenediamine as a specific releasing agent of GABA in rat striatal slices.
- Neurochem. 38, 1168-1169].
Stone TW & Perkins MN. (1984)
Ethylenediamine as a GABA-mimetic.
Trends Pharmacol. Sci. 5, 241-243
8 - the major importance of the kynurenine pathway in cerebral malaria, with survival increased by kynurenine pathway inhibition, and in trypanosomiasis in which brain damage is reduced.
Clark CJ, Mackay GM., Smythe GA, Bustamante S, Stone TW, Phillips RS (2005)
Prolonged survival of a murine model of cerebral malaria by kynurenine pathway inhibition.
Infection and Immunity, 73, 5249-51.
Rodgers J, Stone T W, Barratt MP, Bradley B, Kennedy, P. G. (2009)
Kynurenine pathway inhibition reduces central nervous system inflammation in a model of human African trypanosomiasis.
Brain 132, 1259-1267.
9 – clinical evidence for a potential role of kynurenines in conditions such as Huntington's disease
Forrest CM, Mackay GM, Stoy N, Spiden SL, Taylor R, Stone TW, Darlington LG (2010)
Blood levels of kynurenines, interleukin IL-23 and sHLA-G at different stages of Huntington’s disease.
- Neurochem. 112, 112-122.
10 - the discovery of the selective depletion of cellular tumour suppressors (DCC, Deleted in Colorectal Cancer, neogenin, unc5) by endogenous and bacterial serine proteases, with implications for understanding the initiation and progression of cancer and their potential prevention.
Forrest CM, McNair K, Vincenten MC, Darlington LG, Stone TW. (2016)
Selective depletion of tumour suppressors Deleted in Colorectal Cancer (DCC) and neogenin by environmental and endogenous serine proteases: linking diet and cancer.
BMC Cancer 16:772. DOI: 10.1186/s12885-016-2795-y.
Stone TW, Darlington LG (2017).
Microbial carcinogenic toxins and dietary anti-cancer protectants.
Cell. Molec. Life Sci. 74, 2627-2643.